WO2000044359A3 - Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen - Google Patents

Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen Download PDF

Info

Publication number
WO2000044359A3
WO2000044359A3 PCT/EP2000/000613 EP0000613W WO0044359A3 WO 2000044359 A3 WO2000044359 A3 WO 2000044359A3 EP 0000613 W EP0000613 W EP 0000613W WO 0044359 A3 WO0044359 A3 WO 0044359A3
Authority
WO
WIPO (PCT)
Prior art keywords
infections
utilisation
derivatives
prophylactic
thiadizole
Prior art date
Application number
PCT/EP2000/000613
Other languages
English (en)
French (fr)
Other versions
WO2000044359A2 (de
Inventor
Hassan Jomaa
Original Assignee
Hassan Jomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassan Jomaa filed Critical Hassan Jomaa
Priority to AU27989/00A priority Critical patent/AU2798900A/en
Publication of WO2000044359A2 publication Critical patent/WO2000044359A2/de
Publication of WO2000044359A3 publication Critical patent/WO2000044359A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Verwendung von Thiadiazolderivaten der allgemeinen Formel (I) zur therapeutischen und prophylaktischen Behandlung von Infektionen bei Mensch und Tier, verursacht durch Viren, Bakterien, Pilze und Parasiten, und als Fungizid, Bakterizid und Herbizid bei Pflanzen.
PCT/EP2000/000613 1999-01-29 2000-01-27 Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen WO2000044359A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU27989/00A AU2798900A (en) 1999-01-29 2000-01-27 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19903398.6 1999-01-29
DE19903398A DE19903398A1 (de) 1999-01-29 1999-01-29 Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen

Publications (2)

Publication Number Publication Date
WO2000044359A2 WO2000044359A2 (de) 2000-08-03
WO2000044359A3 true WO2000044359A3 (de) 2000-09-28

Family

ID=7895681

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/000613 WO2000044359A2 (de) 1999-01-29 2000-01-27 Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen

Country Status (3)

Country Link
AU (1) AU2798900A (de)
DE (1) DE19903398A1 (de)
WO (1) WO2000044359A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK288015B6 (sk) * 2001-06-11 2012-11-05 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
US8329924B2 (en) 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN100413861C (zh) 2002-12-10 2008-08-27 维勒凯姆制药股份有限公司 用于治疗或预防黄病毒感染的化合物
AP2007004245A0 (en) 2005-05-13 2007-12-31 Virochem Pharma Inc Compounds and methods for the treatment or prevention of flavivirus infections
NZ576780A (en) 2006-11-15 2011-12-22 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
EP3025714B9 (de) * 2007-09-14 2020-11-18 Biogen MA Inc. Zusammensetzungen und verfahren zur behandlung von progressiver multifokaler leukoenzephalopathie (pml)
CN102626415B (zh) * 2012-03-21 2014-08-06 山东省千佛山医院 四环素类药物联合应用氟康唑在制备抗真菌产品中的应用及其产品
AU2014348451A1 (en) * 2013-11-14 2016-06-16 Avista Pharma Solutions, Inc. Antiparasitic compounds
JP2017529393A (ja) 2014-09-12 2017-10-05 アンティバイオティクス エーピーエスＡｎｔｉｂｉｏｔｘ Ａｐｓ ハロゲン化サリチルアニリドの抗菌用途
CN104606215B (zh) * 2014-12-31 2017-10-10 中国医学科学院病原生物学研究所 一种抑制肠道病毒71的药物
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN112294795B (zh) * 2020-11-17 2022-03-29 北京化工大学 蒿甲醚在治疗和预防柯萨奇病毒感染中的应用
CN115109053A (zh) * 2022-06-08 2022-09-27 深圳湾实验室 噻唑亚磺酰基噻二唑类衍生物、中间体、制备方法以及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07233157A (ja) * 1994-02-18 1995-09-05 Sagami Chem Res Center １，２，３−チアジアゾール誘導体
JPH07233069A (ja) * 1994-02-18 1995-09-05 Sagami Chem Res Center １，２，３−チアジアゾール誘導体を有効成分とする５−リポキシゲナーゼ阻害剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07233157A (ja) * 1994-02-18 1995-09-05 Sagami Chem Res Center １，２，３−チアジアゾール誘導体
JPH07233069A (ja) * 1994-02-18 1995-09-05 Sagami Chem Res Center １，２，３−チアジアゾール誘導体を有効成分とする５−リポキシゲナーゼ阻害剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199544, Derwent World Patents Index; Class B03, AN 1995-340194, XP002138416 *
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 01 31 January 1996 (1996-01-31) *

Also Published As

Publication number Publication date
WO2000044359A2 (de) 2000-08-03
DE19903398A1 (de) 2000-08-10
AU2798900A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
WO1999052515A3 (de) Verwendung von phosphororganischen verbindungen zur therapeutischen und prophylaktischen behandlung von infektionen
WO2000044359A3 (de) Verwendung von thiadiazolderivaten zur prophylaktischen und therapeutischen behandlung von infektionen
WO2000031082A8 (en) Pyrimidin-4-enamine as fungicide
WO2001028339A3 (en) Antimicrobial compositions comprising a biologically active organic acid
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU3707100A (en) The use of specific terpenes to kill, impede, render inactive, or inhibit the growth of plants, bacteria, fungi, yeasts, viruses, and insects, parasites
YU2201A (sh) Fosfororganska jedinjenja i njihova upotreba
WO2000016757A8 (de) Verwendung von phosphororganischen verbindungen zur herstellung von arzneimitteln zur therapeutischen und prophylaktischen behandlung von infektionen oder als fungizid, bakterizid oder herbizid bei pflanzen
WO2000066094A3 (de) Verwendung von verbindungen mit einem stickstoff-sauerstoff-heterocyclus als antiinfektiöse mittel
NO20012541L (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
WO2004043928A3 (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
WO2000044358A3 (de) Verwendung von phosphororganischen verbindungen zur prophylaktischen und therapeutischen behandlung von infektionen
NO20012540L (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
WO2003007878A3 (en) Antifungal agents of sordarin derivatives
AU5066600A (en) Alpha-phenyl-beta-ketosulfone
WO2003017766A3 (de) Herbizide auf basis von substituierten arylketonen
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
WO1999063827A8 (fr) Agents permettant de lutter contre les dommages causes par des maladies bacteriennes dans les domaines de l'agriculture et de l'horticulture
WO2002028183A8 (en) Fungicides
WO2000041473A3 (de) Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen
WO2001049668A3 (de) 4-aryl-1-difluormethoxyimidazole und deren verwendung als herbizide
DE50104130D1 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iii
WO2002002115A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei mensch und tier

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/00803/MU

Country of ref document: IN

122 Ep: pct application non-entry in european phase